Company Number: 15020740

Analysis Date: 2025-07-19 12:55 UTC

Financial Health Assessment for Pharmadyne Consulting Ltd

---

1. Financial Health Score: D

Explanation:
Given the company's financial snapshot at its first year-end, the overall financial position reflects early-stage challenges common in startups but with notable cautionary signs. The negative net current assets and shareholders’ funds indicate liquidity and solvency stress, which prevent a higher grade. The score reflects a company in its infancy with "symptoms of financial distress" requiring close monitoring and corrective action.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets	859	Minimal long-term investment, typical for a new consulting business.
Current Assets	2,529	Limited short-term resources available to meet immediate obligations.
Current Liabilities	5,588	Short-term debts exceed current assets by a significant margin.
Net Current Assets (Working Capital)	-3,059	Negative working capital signals liquidity strain; company may struggle to pay short-term debts.
Total Assets less Current Liabilities	-2,200	Negative net assets indicate liabilities exceed total assets, a "symptom of underlying financial weakness."
Shareholders’ Funds (Equity)	-2,200	Negative equity means the business is "under capitalized" and reliant on external funding or future profits.

Additional Context:

• The company is classified as a Micro entity, implying modest scale and simplified reporting standards.
• Incorporation date: July 2023, so accounts cover just over one year of activity, reflecting a startup phase.
• Average employees: 2, consistent with small operation size.
• No overdue filings, which is positive for compliance and governance.

---

3. Diagnosis

Pharmadyne Consulting Ltd is in the early startup phase, showing typical "infant financial symptoms" such as negative working capital and equity deficit. This is common when initial expenses and liabilities accumulate before significant revenue generation. The company shows:

• Liquidity distress: Negative net current assets suggest it currently lacks sufficient liquid resources to cover short-term obligations. This is a warning sign requiring urgent attention to avoid cash flow crises.
• Under capitalization: Negative shareholders’ funds suggest the company has funded operations through liabilities rather than retained earnings or capital injections.
• Limited asset base: Fixed assets are minimal, indicating low investment in infrastructure or equipment, consistent with consulting services relying on human capital.
• No audit requirement: Reflects small size and micro-entity status, but also limits external scrutiny.

The financial "symptoms" point to a business still establishing its footing and reliant on future operational improvements or capital infusion to turn around its balance sheet.

---

4. Recommendations

To strengthen the financial health and improve prognosis, Pharmadyne Consulting Ltd should consider:

• Cash flow management: Implement rigorous cash flow forecasting to ensure incoming funds cover near-term liabilities. Prioritize collection of receivables and manage payables prudently.
• Capital injection: Explore options for equity funding or director loans to improve working capital and reduce reliance on short-term creditors.
• Cost control: Monitor and control operating expenses closely to avoid further erosion of net assets.
• Revenue growth: Focus on accelerating client acquisition and contract wins to generate sustainable cash inflows.
• Financial reporting: Maintain timely and accurate filings to uphold compliance and build stakeholder confidence.
• Stakeholder communication: Keep investors and creditors informed about turnaround plans to sustain support.

If these measures are implemented effectively, the company can move from a fragile financial state to a more stable and healthy position over the next 12-24 months.

---